27
Apr
FDA links asthma drug to Heart problems
The Food and Drug Administration has announced that the asthma drug Xolair may increase the risk of patients developing a host of cardiovascular problems. Data gathered from clinic trials showed that Xolair users were disproportionately more likely to suffer from blood clots, hea...
View More